Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC-Reference-Cited by-同舟云学术

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Published:2021-11 Issue: Volume: Page:
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Wu Yi-Long^ORCID,John Thomas,Grohe Christian,Majem Margarita,Goldman Jonathan W.,Kim Sang-We,Kato Terufumi,Laktionov Konstantin,Vu Huu Vinh,Wang Zhijie,Lu Shun,Lee Kye Young,Akewanlop Charuwan,Yu Chong-Jen,de Marinis Filippo,Bonanno Laura,Domine Manuel,Shepherd Frances A.,Zeng Lingmin,Atasoy Ajlan,Herbst Roy S.,Tsuboi Masahiro

Funder

AstraZeneca PLC

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Preoperative evaluation of patients undergoing lung resection surgery;Datta;Chest,2003

2. Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?;Le Chevalier;Ann Oncol,2010

3. Lung cancer biomarkers: present status and future developments;Cagle;Arch Pathol Lab Med,2013

4. The IASLC Lung Cancer Staging Project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer;Chansky;J Thorac Oncol,2017

5. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Postmus;Ann Oncol,2017

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redefining Recovery: The Transformative Impact of the ALINA Trial on Adjuvant Therapy for ALK-Positive Non-Small Cell Lung Cancer;Lung Cancer: Targets and Therapy;2024-08

2. A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study);Lung Cancer;2024-08

3. Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future Challenges;Cancers;2024-07-22

4. Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104);Cell Reports Medicine;2024-07

5. Predictive [18F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung Cancer;Academic Radiology;2024-07